OPTUS Pharmaceutical Co., Ltd.

KOSDAQ:A131030 Stock Report

Market Cap: ₩87.7b

OPTUS Pharmaceutical Balance Sheet Health

Financial Health criteria checks 6/6

OPTUS Pharmaceutical has a total shareholder equity of ₩137.7B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩152.3B and ₩14.6B respectively. OPTUS Pharmaceutical's EBIT is ₩8.3B making its interest coverage ratio -3.5. It has cash and short-term investments of ₩67.7B.

Key information

0%

Debt to equity ratio

₩0

Debt

Interest coverage ratio-3.5x
Cash₩67.66b
Equity₩137.73b
Total liabilities₩14.59b
Total assets₩152.32b

Recent financial health updates

No updates

Recent updates

Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Nov 14
Benign Growth For OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030) Underpins Stock's 25% Plummet

Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Nov 13
Investors Could Be Concerned With OPTUS Pharmaceutical's (KOSDAQ:131030) Returns On Capital

Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

Aug 07
Capital Allocation Trends At OPTUS Pharmaceutical (KOSDAQ:131030) Aren't Ideal

There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

Jun 27
There's Reason For Concern Over OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Massive 28% Price Jump

There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

Mar 25
There's No Escaping OPTUS Pharmaceutical Co., Ltd.'s (KOSDAQ:131030) Muted Earnings Despite A 43% Share Price Rise

OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

Mar 13
OPTUS Pharmaceutical's (KOSDAQ:131030) Earnings Are Of Questionable Quality

The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence

Apr 05
The Returns On Capital At DHP Korea (KOSDAQ:131030) Don't Inspire Confidence

DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

Mar 09
DHP Korea's (KOSDAQ:131030) Problems Go Beyond Weak Profit

DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 10
DHP Korea Co., Ltd.'s (KOSDAQ:131030) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 12
How Much Did DHP Korea's(KOSDAQ:131030) Shareholders Earn From Share Price Movements Over The Last Five Years?

Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

Dec 08
Should We Be Excited About The Trends Of Returns At DHP Korea (KOSDAQ:131030)?

Financial Position Analysis

Short Term Liabilities: A131030's short term assets (₩92.6B) exceed its short term liabilities (₩12.7B).

Long Term Liabilities: A131030's short term assets (₩92.6B) exceed its long term liabilities (₩1.8B).


Debt to Equity History and Analysis

Debt Level: A131030 is debt free.

Reducing Debt: A131030 had no debt 5 years ago.

Debt Coverage: A131030 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: A131030 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies